ATE349243T1 - Kombination von einem pde-hemmer und eines leukotrien rezeptor antagonisten - Google Patents

Kombination von einem pde-hemmer und eines leukotrien rezeptor antagonisten

Info

Publication number
ATE349243T1
ATE349243T1 AT02798730T AT02798730T ATE349243T1 AT E349243 T1 ATE349243 T1 AT E349243T1 AT 02798730 T AT02798730 T AT 02798730T AT 02798730 T AT02798730 T AT 02798730T AT E349243 T1 ATE349243 T1 AT E349243T1
Authority
AT
Austria
Prior art keywords
leucotrien
combination
receptor antagonist
pde inhibitor
pde
Prior art date
Application number
AT02798730T
Other languages
English (en)
Inventor
Rolf Beume
Christian Weimar
Stefan-Lutz Wollin
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of ATE349243T1 publication Critical patent/ATE349243T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02798730T 2001-09-19 2002-09-17 Kombination von einem pde-hemmer und eines leukotrien rezeptor antagonisten ATE349243T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01000474 2001-09-19

Publications (1)

Publication Number Publication Date
ATE349243T1 true ATE349243T1 (de) 2007-01-15

Family

ID=8176066

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02798730T ATE349243T1 (de) 2001-09-19 2002-09-17 Kombination von einem pde-hemmer und eines leukotrien rezeptor antagonisten

Country Status (25)

Country Link
US (1) US20050014762A1 (de)
EP (1) EP1429843B1 (de)
JP (1) JP2005505570A (de)
KR (1) KR20040044946A (de)
CN (1) CN100346831C (de)
AT (1) ATE349243T1 (de)
BR (1) BR0212582A (de)
CA (1) CA2460442A1 (de)
CO (1) CO5560584A2 (de)
CY (1) CY1106365T1 (de)
DE (1) DE60217139T2 (de)
DK (1) DK1429843T3 (de)
EA (1) EA007736B1 (de)
ES (1) ES2279004T3 (de)
HU (1) HUP0500078A3 (de)
IL (2) IL160272A0 (de)
MA (1) MA27136A1 (de)
MX (1) MXPA04002560A (de)
NO (1) NO331885B1 (de)
NZ (1) NZ532279A (de)
PL (1) PL205927B1 (de)
PT (1) PT1429843E (de)
SI (1) SI1429843T1 (de)
WO (1) WO2003024488A2 (de)
ZA (1) ZA200402653B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0719518D0 (en) * 2007-10-05 2007-11-14 Therapeutics Ltd E Therapy
AU2008316283A1 (en) * 2007-10-25 2009-04-30 Merck Frosst Canada Ltd Inhalation compositions comprising montelukast acid and a PDE-4 inhibitor or an inhaled corticosteroid
WO2012168907A1 (en) * 2011-06-10 2012-12-13 Glenmark Pharmaceuticals Sa Pharmaceutical composition comprising revamilast and montelukast or zafirlukast
WO2014012954A1 (en) 2012-07-18 2014-01-23 Takeda Gmbh Treatment of partly controlled or uncontrolled severe asthma
EA201591360A1 (ru) 2013-02-19 2016-03-31 Пфайзер Инк. Азабензимидазолы в качестве ингибиторов изозимов фдэ4 для лечения цнс и других расстройств
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof
JP2017503814A (ja) 2014-01-22 2017-02-02 タケダ ゲー・エム・ベー・ハーＴａｋｅｄａ ＧｍｂＨ 部分的コントロール状態の重症喘息またはコントロール不良状態の重症喘息のｐｄｅ４インヒビターを用いた（およびロイコトリエン調節薬と組み合わせて用いた）治療
JP6713982B2 (ja) 2014-07-24 2020-06-24 ファイザー・インク ピラゾロピリミジン化合物
AP2017009744A0 (en) 2014-08-06 2017-02-28 Pfizer Imidazopyridazine compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY121142A (en) * 1999-02-23 2005-12-30 Smithkline Beecham Corp Controlled release formulation for treating copd
SK287231B6 (sk) * 1999-08-21 2010-04-07 Nycomed Gmbh Liečivo zahŕňajúce PDE inhibítor a agonistu beta2 adrenoreceptora
MY134008A (en) * 1999-12-22 2007-11-30 Merck Frosst Canada Inc Subtituted 8-arylquinoline phospohodiestrase-4 inhibitors
NZ519547A (en) * 2000-01-31 2004-03-26 Pfizer Prod Inc Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes
MY123585A (en) * 2000-03-23 2006-05-31 Merck Canada Inc Tri-aryl-substituted-ethane pde4 inhibitors.
EP1289961A1 (de) * 2000-05-25 2003-03-12 Merck Frosst Canada & Co. Fluoroalkoxy-substituiertes benzamid-dichloropyridinyl-n-oxid als pde4 inhibitor

Also Published As

Publication number Publication date
CY1106365T1 (el) 2011-10-12
WO2003024488A3 (en) 2003-09-04
CN1655846A (zh) 2005-08-17
CN100346831C (zh) 2007-11-07
MA27136A1 (fr) 2005-01-03
MXPA04002560A (es) 2004-05-31
KR20040044946A (ko) 2004-05-31
BR0212582A (pt) 2004-10-13
NZ532279A (en) 2006-02-24
DE60217139D1 (de) 2007-02-08
EP1429843A2 (de) 2004-06-23
US20050014762A1 (en) 2005-01-20
NO20041595L (no) 2004-06-16
HUP0500078A3 (en) 2010-07-28
EA007736B1 (ru) 2006-12-29
ZA200402653B (en) 2005-02-14
DE60217139T2 (de) 2007-10-04
NO331885B1 (no) 2012-04-30
HUP0500078A2 (hu) 2005-04-28
JP2005505570A (ja) 2005-02-24
EA200400416A1 (ru) 2004-12-30
CA2460442A1 (en) 2003-03-27
CO5560584A2 (es) 2005-09-30
EP1429843B1 (de) 2006-12-27
ES2279004T3 (es) 2007-08-16
HK1066752A1 (en) 2005-04-01
DK1429843T3 (da) 2007-04-30
IL160272A (en) 2008-03-20
PL367414A1 (en) 2005-02-21
PT1429843E (pt) 2007-03-30
IL160272A0 (en) 2004-07-25
PL205927B1 (pl) 2010-06-30
SI1429843T1 (sl) 2007-06-30
WO2003024488A2 (en) 2003-03-27

Similar Documents

Publication Publication Date Title
ATE414519T1 (de) Kombination aus einem nmda-antagonist und acetylcholinesterase-hemmern zur behandlung der alzheimer-krankheit
CY1106927T1 (el) Φαρμακευτικη συνθεση ενος pde4 ή pde3/4 αναστολεα και ανταγωνιστη υποδοχεα ισταμινης
CY1106365T1 (el) Συνδυασμος ενος αναστολεα pde και ενος ανταγωνιστη υποδοχεων λευκοτριενιου
MA25809A1 (fr) Derives d'arylmethylamine pour usage comme inhibiteurs de tryptase
WO2004092166A3 (en) Cgrp receptor antagonists
ATE371656T1 (de) Heteroaryl-pyrimidinderivate als jak-inhibitoren
NO20071560L (no) Vasopressin v1a-antagonister.
WO2005072308A3 (en) Cgrp receptor antagonists
DE60216745D1 (de) Carbolin Derivate als Hemmstoffe von Phospphodiesterase 5 (PDE5) zur Behandlung kardiovaskulärer Erkrankungen und der erektilen Dysfunktion
WO2002081728A3 (en) Quinoline inhibitors of hyak1 and hyak3 kinases
DE602005027230D1 (de) Cgrp-rezeptorantagonisten
NO20033417D0 (no) Anvendelse av CD23-antagonister for behandling av neoplastiske forstyrrelser
ID29818A (id) Penggunaan antagonis reseptor angiotensin ii untuk mengobati infarksi miokardial
MA27539A1 (fr) Nouvelle combinaison synergique contenant du roflumilast et du formoterol
HUP0401858A3 (en) Gal3 receptor antagonist pyrimidine and indolone-derivatives and their use for preparation of pharmaceutical compositions suitable for the treatment of depression and/or anxiety
NO20026085L (no) Ny anvendelse av angiotensin II antagonister
HUP0303754A3 (en) Use of radical scavenging compounds for preparation of pharmaceutical compsoition suitable for treatment and prevention of no-dependent microcirculation disorders
BRPI0419110A (pt) antagonistas de bifenil integrina

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1429843

Country of ref document: EP

EEIH Change in the person of patent owner